US HB5353 | 2017-2018 | 115th Congress
Status
Spectrum: Bipartisan Bill
Status: Engrossed on June 13 2018 - 50% progression, died in committee
Action: 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on June 13 2018 - 50% progression, died in committee
Action: 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Eliminating Opioid Related Infectious Diseases Act of 2018 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention to expand its grant program for combating hepatitis C infections to include other infections associated with injection drug use.
Title
Eliminating Opioid Related Infectious Diseases Act of 2018
Sponsors
Rep. Leonard Lance [R-NJ] | Rep. Joseph Kennedy [D-MA] | Rep. Chris Collins [R-NY] | Rep. Anna Eshoo [D-CA] |
Rep. Joe Barton [R-TX] | Rep. Doris Matsui [D-CA] | Rep. Raul Grijalva [D-AZ] | Rep. Yvette Clarke [D-NY] |
Rep. Mark Pocan [D-WI] | Rep. Michelle Lujan Grisham [D-NM] | Sen. Marsha Blackburn [R-TN] | Rep. Greg Walden [R-OR] |
Rep. Jaime Herrera Beutler [R-WA] | Rep. Peter King [R-NY] | Rep. Rodney Davis [R-IL] |
History
Date | Chamber | Action |
---|---|---|
2018-06-13 | Senate | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
2018-06-12 | House | Motion to reconsider laid on the table Agreed to without objection. |
2018-06-12 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059) |
2018-06-12 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 5353. |
2018-06-12 | House | Considered under suspension of the rules. (consideration: CR H5059-5060) |
2018-06-12 | House | Mr. Walden moved to suspend the rules and pass the bill, as amended. |
2018-05-09 | House | Ordered to be Reported (Amended) by Voice Vote. |
2018-05-09 | House | Committee Consideration and Mark-up Session Held. |
2018-04-25 | House | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . |
2018-04-25 | House | Subcommittee Consideration and Mark-up Session Held. |
2018-04-25 | House | Referred to the Subcommittee on Health. |
2018-03-20 | House | Referred to the House Committee on Energy and Commerce. |
2018-03-20 | House | Introduced in House |
Same As/Similar To
SB2579 (Same As) 2018-03-20 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Digestive and metabolic diseases
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
HIV/AIDS
Indian social and development programs
Infectious and parasitic diseases
Medical education
Minority health
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
HIV/AIDS
Indian social and development programs
Infectious and parasitic diseases
Medical education
Minority health